HLX-Reta 10

Retatrutide is a cutting-edge tri-agonist engineered to simultaneously target GLP-1, GIP, and Glucagon (GCGR) receptors. This compound provides researchers with an unprecedented mechanism to observe complex, multi-system metabolic signaling and the cascading effects of triple-receptor activation in vitro.

Primary Research Applications

• Tri-receptor (GLP-1/GIP/GCGR) simultaneous agonism.

• Advanced cellular energy expenditure modeling.

• Glucagon receptor pathway integration studies.

Compound Specifications

• Class: GLP-1/GIP/GCGR Tri-Agonist

• Purity: ≥99% (HPLC Verified)

• Format: Lyophilized Solid

• Storage: -20°C (Refrigeration required post-reconstitution)

⚠️ COMPLIANCE NOTICE: strictly for in-vitro and laboratory research use only. Not for human or animal consumption.